Article Detail - JE Part B
Billing and Coding: MolDX: myPath® Melanoma Assay (A57626) - R3 - Effective January 01, 2022
This Billing and Coding Article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Effective Date: January 01, 2022
Summary of Article Changes:
Under CPT/HCPCS Codes Group 1: Codes the description was revised for 0090U. This revision is due to the 2022 Annual CPT/HCPCS code update
Visit the Molecular Diagnostic Services (MolDX) webpage to access the locally hosted MolDX Medicare Coverage Article from the “Covered Tests” or the “Excluded Tests” webpage.
To view the complete listing of locally hosted coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.
Last Updated Mon, 28 Feb 2022 18:17:00 +0000